Obesity increases intra-abdominal pressure and places additional strain on leg veins, impairing venous return
GLP-1 medications, such as semaglutide (the active ingredient in Ozempic and Wegovy), have gained global attention for their ability to help people lose significant weight while improving insulin sensitivity and reducing appetite
For instance, nanoparticle-based inhalers have been shown to increase lung deposition of medications by up to 3.68 times more compared to traditional inhalers, potentially revolutionizing the treatment of conditions like cystic fibrosis and severe asthma
1, 5, or 10 mg/kg), and ATO+MTX
Side effect profile differences Sublingual drops tend to produce milder GI side effects compared to injections, particularly during the dose escalation phase